Allergic reactions against Covıd-19 vaccines

Ünsal, Hilal; SAHINER, Umit; Şekerel, Bülent

doi:10.3906/sag-2104-329

Allergic reactions against Covıd-19 vaccines

Hilal ÜNSAL, (Hacettepe Üniversitesi, Tıp Fakültesi, Pediatrik Alerji Anabilim Dalı, Ankara, Türkiye)

Bülent Enis ŞEKEREL, (Hacettepe Üniversitesi, Tıp Fakültesi, Pediatrik Alerji Anabilim Dalı, Ankara, Türkiye)

Ümit Murat ŞAHINER (Hacettepe Üniversitesi, Tıp Fakültesi, Pediatrik Alerji Anabilim Dalı, Ankara, Türkiye)

Turkish Journal of Medical Sciences

2 1

Yıl: 2021 Cilt: 51 Sayı: 5 Sayfa Aralığı: 2233 - 2242 Metin Dili: İngilizce DOI: 10.3906/sag-2104-329 İndeks Tarihi: 06-01-2022

Allergic reactions against Covıd-19 vaccines

Öz:

Abstract: Coronavirus Disease 2019 (COVID-19) affected the whole world in a short time. One of the most influential public health initiatives modern medicine has to offer, the vaccine has become even more important as the COVID-19 pandemic continues to worsen worldwide. Many vaccine trials were launched during the COVID-19 pandemic, and these vaccines were widely used around the world, offering realistic hope for ending the pandemic. Allergic reactions to vaccines were reported shortly after their approval. These reactions, in general, are rare, but, in some circumstances, they can be serious. Allergy to vaccines can occur because of either the active vaccine component or vaccine ingredients. The spectrum of the reactions may be just a local hypersensitiviy reaction or may be as severe as an anaphylaxis, which is an acute severe, life-threatening systemic hypersensitive reaction, and it requires quick intervention. If an allergy is suspected, a correct examination followed by algorithms is important for true diagnosis, treatment, and decision regarding revaccination. Patients who experience an allergic reaction with the first dose of covid 19 vaccine should be directed to the allergyimmunologist, and the evaluation of at-risk patients should be individualized. Finally, we should point out that the benefits of current COVID-19 vaccines go far beyond the side effects, and that the vaccine is the most important way to recover from the pandemic.Key words: COVID-19, vaccine, allergy, hypersensitiviy, polyethylene glycol

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Delany I, Rappuoli R, De Gregorio E. Vaccines for the 21st century. EMBO Molecular Medicine. 2014; 6 (6): 708-720. doi: 10.1002/emmm.201403876
2. Whitney CG, Zhou F, Singleton J, Schuchat A. Benefits from immunization during the vaccines for children program era— United States, 1994–2013. MMWR Morbidity and Mortality Weekly Report. 2014; 63 (16): 352
3. McNeil MM, Weintraub ES, Duffy J, Sukumaran L, Jacobsen SJ et al. Risk of anaphylaxis after vaccination in children and adults. Journal of Allergy and Clinical Immunology. 2016; 137 (3): 868-878. doi: 10.1016/j.jaci.2015.07.048
4. Kelso JM. Anaphylactic reactions to novel mRNA SARSCoV-2/COVID-19 vaccines. Vaccine. 2021; 39 (6): 865. doi: 10.1016/j.vaccine.2020.12.084
5. Murphy KR, Patel NC, Ein D, Hudelson M, Kodoth S et al. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines: Allergic Reactions to mRNA SARS-CoV-2 Vaccines. Annals of Allergy, Asthma & Immunology. 2021. doi: 10.1016/j.anai.2021.01.017
6. COVID C, Team R. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report. 2021; 70 (2): 46. doi: 10.15585/ mmwr.mm7002e1
7. COVID C, Team R. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine—United States, December 21, 2020–January 10, 2021. Morbidity and Mortality Weekly Report. 2021; 70 (4): 125. doi: 10.15585/mmwr.mm7004e1
8. Echeverría-Zudaire LA, Ortigosa-del Castillo L, AlonsoLebrero E, Álvarez-García FJ, Cortés-Álvarez N et al. Consensus document on the approach to children with allergic reactions after vaccination or allergy to vaccine components. Allergologia et Immunopathologia. 2015; 43 (3): 304-325. doi: 10.1016/j.aller.2015.01.004
9. Simons FER, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organization Journal. 2015; 8: 32. doi: 10.1186/s40413-015- 0080-1
10. McNeil MM, DeStefano F. Vaccine-associated hypersensitivity. Journal of Allergy and Clinical Immunology. 2018; 141 (2): 463-472. doi: 10.1016/j.jaci.2017.12.971
11. Stone Jr CA, Rukasin CR, Beachkofsky TM, Phillips EJ. Immune-mediated adverse reactions to vaccines. British Journal of Clinical Pharmacology. 2019; 85 (12): 2694-2706. doi: 10.1111/bcp.14112
12. da Silva EZM, Jamur MC, Oliver C. Mast cell function: a new vision of an old cell. Journal of Histochemistry & Cytochemistry. 2014; 62 (10): 698-738. doi: 10.1369/0022155414545334
13. Porebski G, Kwiecien K, Pawica M, Kwitniewski M. Masrelated G protein-coupled receptor-X2 (MRGPRX2) in drug hypersensitivity reactions. Frontiers in Immunology. 2018; 9: 3027. doi: 10.3389/fimmu.2018.03027
14. Spoerl D, Nigolian H, Czarnetzki C, Harr T. Reclassifying anaphylaxis to neuromuscular blocking agents based on the presumed patho-mechanism: IgE-mediated, pharmacological adverse reaction or “innate hypersensitivity”? International Journal of Molecular Sciences. 2017; 18 (6): 1223. doi: 10.3390/ ijms18061223
15. Wood RA, Berger M, Dreskin SC, Setse R, Engler RJ et al. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics. 2008; 122 (3): e771-e777. doi: 10.1542/peds.2008-1002
16. Johansson S, Hourihane JB, Bousquet J, Bruijnzeel-Koomen C, Dreborg S et al. A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy. 2001; 56 (9): 813-824. doi: 10.1034/j.1398-9995.2001. t01-1-00001.x
17. Kelso JM, Greenhawt MJ, Li JT, Nicklas RA, Bernstein DI et al. Adverse reactions to vaccines practice parameter 2012 update. Journal of Allergy and Clinical Immunology. 2012; 130 (1): 25- 43. doi: 10.1016/j.jaci.2012.04.003
18. Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS et al. International Consensus (ICON): allergic reactions to vaccines. World Allergy Organization Journal. 2016; 9 (1): 32. doi: 10.1186/s40413-016-0120-5
19. Muraro A, Roberts G, Worm M, Bilò M, Brockow K et al. Anaphylaxis: guidelines from the E uropean A cademy of A llergy and C linical I mmunology. Allergy. 2014; 69 (8): 1026- 1045. doi: 10.1111/all.12437
20. Johansson S, Bieber T, Dahl R, Friedmann PS, Lanier BQ et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. Journal of Allergy and Clinical Immunology. 2004; 113 (5): 832-836. doi: 10.1016/j. jaci.2003.12.591
21. Anaphylaxis; Turkish National Guideline 2018; Volume: 16, Supplement: 1, 2018, editor; Orhan F. Asthma Allergy Immunology.
22. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson Jr NF, Bock SA et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Journal of Allergy and Clinical Immunology. 2006; 117 (2): 391-397. doi: 10.1016/j.jaci.2005.12.1303
23. Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. Journal of Allergy and Clinical Immunology. 2004; 113 (3): 536-542. doi: 10.1016/j.jaci.2003.11.033
24. Brown SG. Clinical features and severity grading of anaphylaxis. Journal of Allergy and Clinical Immunology. 2004; 114 (2): 371-376. doi: 10.1016/j.jaci.2004.04.029
25. Vanlander A, Hoppenbrouwers K. Anaphylaxis after vaccination of children: review of literature and recommendations for vaccination in child and school health services in Belgium. Vaccine. 2014; 32 (26): 3147-3154. doi: 10.1016/j.vaccine.2014.03.096
26. Control CfD, Prevention. Syncope after vaccination--United States, January 2005-July 2007. MMWR Morbidity and Mortality Weekly Report. 2008; 57 (17): 457-460
27. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Current Opinion in Allergy and Clinical Immunology. 2005; 5 (4): 359-364. doi: 10.1097/01. all.0000174158.78626.35
28. Caubet J-C, Ponvert C. Vaccine Allergy. Immunology and Allergy Clinics. 2014; 34 (3): 597-613. doi: 10.1016/j. iac.2014.04.004
29. Bergfors E, Trollfors B. Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines—prognosis and outcome after booster vaccination. European Journal of Pediatrics. 2013; 172 (2): 171-177. doi: 10.1007/s00431-012- 1841-2
30. Nilsson L, Brockow K, Alm J, Cardona V, Caubet JC et al. Vaccination and allergy: EAACI position paper, practical aspects. Pediatric Allergy and Immunology. 2017; 28 (7): 628- 640. doi: 10.1111/pai.12762
31. Jackson LA, Starkovich P, Dunstan M, Yu O, Nelson J et al. Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination. Pediatrics. 2008; 121 (3): e646-e652. doi: 10.1542/peds.2007-1653
32. Jackson LA, Peterson D, Nelson JC, Marcy SM, Naleway AL et al. Vaccination site and risk of local reactions in children 1 through 6 years of age. Pediatrics. 2013; 131 (2): 283-289. doi: 10.1542/peds.2012-2617
33. for Immunization NC. General recommendations on immunization---recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. 2011; 60 (2): 1-64
34. Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS et al. International Consensus (ICON): allergic reactions to vaccines. World Allergy Organization Journal. 2016; 9 (1): 1-21. doi: 10.1186/s40413-016-0120-5
35. Turner PJ, Ansotegui IJ, Campbell DE, Cardona V, Ebisawa M et al. COVID-19 Vaccine-associated anaphylaxis: a statement of the world allergy organization anaphylaxis committee. World Allergy Organization Journal. 2021: 100517. doi: 10.1016/j.waojou.2021.100517
36. Banerji A, Wickner PG, Saff R, Stone Jr CA, Robinson LB et al. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Approach. The Journal of Allergy and Clinical Immunology: In Practice. 2020. doi: 10.1016/j.jaip.2020.12.047
37. Kleine-Tebbe J, Klimek L, Hamelmann E, Pfaar O, Taube C et al. Severe allergic reactions to the COVID-19 vaccine– statement and practical consequences. Allergologie Select. 2021; 5: 26. doi: 10.5414/ALX02215E
38. Sellaturay P, Nasser S, Ewan P. Polyethylene Glycol–Induced Systemic Allergic Reactions (Anaphylaxis). The Journal of Allergy and Clinical Immunology: In Practice. 2021; 9 (2): 670- 675. doi: 10.1016/j.jaip.2020.09.029
39. Bruusgaard-Mouritsen MA, Johansen JD, Garvey LH. Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients. Clinical & Experimental Allergy. doi: 10.1111/cea.13822
40. Wenande E, Garvey L. Immediate-type hypersensitivity to polyethylene glycols: a review. Clinical & Experimental Allergy. 2016; 46 (7): 907-922. doi: 10.1111/cea.12760
41. Zhou Z-H, Stone Jr CA, Jakubovic B, Phillips EJ, Sussman G et al. Anti-PEG IgE in anaphylaxis associated with polyethylene glycol. The Journal of Allergy and Clinical Immunology: In Practice. 2020. doi: 10.1016/j.jaip.2020.11.011
42. Stone Jr CA, Liu Y, Relling MV, Krantz MS, Pratt AL et al. Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized. The Journal of Allergy and Clinical Immunology: In Practice. 2019; 7 (5): 1533-1540. e8. doi: 10.1016/j.jaip.2018.12.003
43. Fruijtier-Pölloth C. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products. Toxicology. 2005; 214 (1-2): 1-38. doi: 10.1016/j. tox.2005.06.001
44. Sahiner UM, Yavuz ST, Gökce M, Buyuktiryaki B, Altan I et al. Anaphylactic reaction to polyethylene-glycol conjugatedasparaginase: Premedication and desensitization may not be sufficient. Pediatrics International. 2013; 55 (4): 531-533. doi: 10.1111/ped.12131
45. Szebeni J, Fontana JL, Wassef NM, Mongan PD, Morse DS et al. Hemodynamic changes induced by liposomes and liposomeencapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes: role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation. 1999; 99 (17): 2302-2309. doi: 10.1161/01. cir.99.17.2302
46. Mohamed M, Abu Lila AS, Shimizu T, Alaaeldin E, Hussein A et al. PEGylated liposomes: immunological responses. Science and Technology of Advanced Materials. 2019; 20 (1): 710-724. doi: 10.1080/14686996.2019.1627174
47. Coors EA, Seybold H, Merk HF, Mahler V. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Annals of Allergy, Asthma & Immunology. 2005; 95 (6): 593-599. doi: 10.1016/S1081-1206(10)61024-1
48. Hawe A, Filipe V, Jiskoot W. Fluorescent molecular rotors as dyes to characterize polysorbate-containing IgG formulations. Pharmaceutical Research. 2010; 27 (2): 314-326. doi: 10.1007/ s11095-009-0020-2
49. Cabanillas B, Akdis C, Novak N. Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol? : Wiley Online Library; 2020. doi: 10.1111/all.14711
50. Sokolowska M, Eiwegger T, Ollert M, Torres MJ, Barber D et al. EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines. Allergy. doi: 10.1111/all.14739
51. Tanno LK, Gonzalez-Estrada A, Olivieri B, Caminati M. Asthma and anaphylaxis. Current Opinion in Allergy and Clinical Immunology. 2019; 19 (5): 447-455. doi: 10.1097/ ACI.0000000000000566
52. Shaker MS, Wallace DV, Golden DB, Oppenheimer J, Bernstein JA et al. Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. Journal of Allergy and Clinical Immunology. 2020; 145 (4): 1082-1123. doi: 10.1016/j.jaci.2020.01.017
53. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews. 2012 (6). doi: 10.1002/14651858. CD000567.pub5
54. Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Rivas MF et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organization Journal. 2020; 13 (10): 100472. doi: 10.1016/j.waojou.2020.100472
55. Pumphrey R. Lessons for management of anaphylaxis from a study of fatal reactions. Clinical and Experimental Allergy. 2000; 30 (8): 1144-1150. doi: 10.1046/j.1365-2222.2000.00864.x
56. Simons FER, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organization Journal. 2011; 4 (2): 13-37. doi: 10.1097/ WOX.0b013e318211496c
57. Michelson KA, Monuteaux MC, Neuman MI. Glucocorticoids and hospital length of stay for children with anaphylaxis: a retrospective study. The Journal of Pediatrics. 2015; 167 (3): 719-724. e3. doi: 10.1016/j.jpeds.2015.05.033
58. Alqurashi W, Ellis AK. Do corticosteroids prevent biphasic anaphylaxis? The Journal of Allergy and Clinical Immunology: In Practice. 2017; 5 (5): 1194-1205. doi: 10.1016/j. jaip.2017.05.022
59. Thomas M, Crawford I. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emergency Medicine Journal. 2005; 22 (4): 272-273. doi: 10.1136/ emj.2005.023507

APA	Ünsal H, Şekerel B, SAHINER U (2021). Allergic reactions against Covıd-19 vaccines. , 2233 - 2242. 10.3906/sag-2104-329
Chicago	Ünsal Hilal,Şekerel Bülent,SAHINER Umit Allergic reactions against Covıd-19 vaccines. (2021): 2233 - 2242. 10.3906/sag-2104-329
MLA	Ünsal Hilal,Şekerel Bülent,SAHINER Umit Allergic reactions against Covıd-19 vaccines. , 2021, ss.2233 - 2242. 10.3906/sag-2104-329
AMA	Ünsal H,Şekerel B,SAHINER U Allergic reactions against Covıd-19 vaccines. . 2021; 2233 - 2242. 10.3906/sag-2104-329
Vancouver	Ünsal H,Şekerel B,SAHINER U Allergic reactions against Covıd-19 vaccines. . 2021; 2233 - 2242. 10.3906/sag-2104-329
IEEE	Ünsal H,Şekerel B,SAHINER U "Allergic reactions against Covıd-19 vaccines." , ss.2233 - 2242, 2021. 10.3906/sag-2104-329
ISNAD	Ünsal, Hilal vd. "Allergic reactions against Covıd-19 vaccines". (2021), 2233-2242. https://doi.org/10.3906/sag-2104-329

APA	Ünsal H, Şekerel B, SAHINER U (2021). Allergic reactions against Covıd-19 vaccines. Turkish Journal of Medical Sciences, 51(5), 2233 - 2242. 10.3906/sag-2104-329
Chicago	Ünsal Hilal,Şekerel Bülent,SAHINER Umit Allergic reactions against Covıd-19 vaccines. Turkish Journal of Medical Sciences 51, no.5 (2021): 2233 - 2242. 10.3906/sag-2104-329
MLA	Ünsal Hilal,Şekerel Bülent,SAHINER Umit Allergic reactions against Covıd-19 vaccines. Turkish Journal of Medical Sciences, vol.51, no.5, 2021, ss.2233 - 2242. 10.3906/sag-2104-329
AMA	Ünsal H,Şekerel B,SAHINER U Allergic reactions against Covıd-19 vaccines. Turkish Journal of Medical Sciences. 2021; 51(5): 2233 - 2242. 10.3906/sag-2104-329
Vancouver	Ünsal H,Şekerel B,SAHINER U Allergic reactions against Covıd-19 vaccines. Turkish Journal of Medical Sciences. 2021; 51(5): 2233 - 2242. 10.3906/sag-2104-329
IEEE	Ünsal H,Şekerel B,SAHINER U "Allergic reactions against Covıd-19 vaccines." Turkish Journal of Medical Sciences, 51, ss.2233 - 2242, 2021. 10.3906/sag-2104-329
ISNAD	Ünsal, Hilal vd. "Allergic reactions against Covıd-19 vaccines". Turkish Journal of Medical Sciences 51/5 (2021), 2233-2242. https://doi.org/10.3906/sag-2104-329